← Back to Search

Exercise--Rock Steady Boxing class for Parkinson's Disease (FIGHTPD Trial)

N/A
Recruiting
Led By Daniel Claassen, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant agreeable to an overnight dopaminergic medication washout period
Participant is willing and able to participate in a Rock Steady Boxing class
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is designed to measure the change in patients diagnosed with Parkinson's disease before, during and after a 12 week exercise program, with a focus on the glymphatic system.

Eligible Conditions
  • Parkinson's Disease
  • Glymphatic System

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
6 Minute Walk Test
Brief Estimate of Seconds (BEST)
Change in Beta-Amyloid Levels
+11 more
Secondary study objectives
ActiGraphy
Neurametrix

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Exercise--Rock Steady Boxing classExperimental Treatment1 Intervention
Participants will be going twice a week to a Rock Steady Boxing class for an hour/class. Participants will be going to this class for a total of three months.

Find a Location

Who is running the clinical trial?

United States Department of DefenseFED
909 Previous Clinical Trials
333,664 Total Patients Enrolled
Vanderbilt University Medical CenterLead Sponsor
902 Previous Clinical Trials
938,788 Total Patients Enrolled
Daniel Claassen, MDPrincipal Investigator - Associate Professor
Vanderbilt University Hospital
Medical College Of Georgia School Of Medicine (Medical School)
Mayo Grad School Med/Mayo Fndn (Residency)
2 Previous Clinical Trials
115 Total Patients Enrolled
~5 spots leftby Nov 2025